Skip to main content
    R

    Rani Therapeutics Holdings Inc (RANI)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $0.54
    +0.01 (+2.66%)

    Market Cap: $60.78M

    Last updated: Nov 17, 2026 at 11:05 AM ET

    Rani Therapeutics Holdings Inc (RANI) Earnings: Report Dates and Results

    Updated Nov 9, 2026. Results come from company earnings reports, and estimates are consensus analyst estimates.

    Rani Therapeutics Holdings (RANI) is expected to report earnings on Mar 25, 2027. In the quarter ended Sep 30, 2026, Rani Therapeutics Holdings reported EPS of -$0.04, above the -$0.05 estimate. It beat the EPS estimate in 4 of the last 8 quarters.

    Earnings

    Performance (10Y)

    Beat Rate
    74%(17/23)
    Avg Surprise
    +14.41%
    Streak
    2 Q

    Upcoming Estimates

    Reports Mar 25, 2027 (est.)Period ending Dec 31, 2026
    EPS Consensus-$0.05
    Range-$0.06 - -$0.04
    7 analysts
    Revenue Consensus
    $1.63M
    RangeN/A
    7 analysts
    Report date not yet scheduledPeriod ending Mar 31, 2027
    EPS Consensus-$0.05
    Range-$0.05 - -$0.05
    1 analysts
    EPS RevisionsNo revisions (30d)
    EPS Estimate DriftChange to current
    90d ago$0.00n/a
    60d ago$0.00n/a
    30d ago$0.00n/a
    7d ago$0.00n/a
    Current-$0.05
    Revenue Consensus
    N/A
    RangeN/A
    1 analysts

    Next Report

    RANI has an expected report date of Mar 25, 2027.

    Earnings History

    Of the 23 quarters below that had an estimate, RANI beat 17, missed 3 and matched 3. The widest gap in the table came in the quarter ended Mar 31, 2022, when EPS landed 56.06% above the estimate.

    Quarter endedEPSEstimateRangeSurpriseResultYoYAnalystsRevisionsReportedRevenue
    Sep 30, 2026-$0.04-$0.05-$0.05 - -$0.04+20.00%BeatN/A31 up, 0 downNov 9, 2026$1.71M
    Jun 30, 2026-$0.04-$0.05-$0.05 - -$0.05+20.00%BeatN/A31 up, 0 downAug 13, 2026$1.71M
    Mar 31, 2026-$0.04-$0.04-$0.06 - -$0.020.00%In lineN/A41 up, 0 downMay 15, 2026$1.71M
    Dec 31, 2025-$0.07-$0.05-$0.14 - -$0.01-47.37%MissN/A31 up, 1 downMar 26, 2026$1.46M
    Sep 30, 2025-$0.12-$0.12-$0.15 - -$0.090.00%In lineN/A32 up, 0 downNov 6, 2025N/A
    Jun 30, 2025-$0.18-$0.19-$0.20 - -$0.19+5.26%BeatN/A20 up, 0 downAug 7, 2025N/A
    Mar 31, 2025-$0.22-$0.24-$0.24 - -$0.24+8.33%BeatN/A10 up, 0 downMay 13, 2025$172000
    Dec 31, 2024-$0.27-$0.26-$0.28 - -$0.17-3.85%MissN/A31 up, 0 downMar 31, 2025$1.03M
    Sep 30, 2024-$0.24-$0.29-$0.34 - -$0.25+17.24%BeatN/A31 up, 0 downNov 14, 2024N/A
    Jun 30, 2024-$0.26-$0.29-$0.55 - -$0.22+10.34%BeatN/A70 up, 0 downAug 6, 2024N/A
    Mar 31, 2024-$0.29-$0.23-$0.24 - -$0.14-26.09%MissN/A30 up, 0 downMay 6, 2024N/A
    Dec 31, 2023-$0.27-$0.31-$0.37 - -$0.24+12.90%BeatN/A50 up, 0 downMar 20, 2024$2.75M
    Sep 30, 2023-$0.36-$0.37-$0.42 - -$0.30+2.70%BeatN/A60 up, 0 downNov 8, 2023N/A
    Jun 30, 2023-$0.37-$0.42-$0.71 - -$0.33+11.90%BeatN/A70 up, 0 downAug 11, 2023N/A
    Mar 31, 2023-$0.33-$0.43-$0.69 - -$0.33+23.26%BeatN/A60 up, 0 downMay 10, 2023N/A
    Dec 31, 2022-$0.35-$0.35-$0.54 - -$0.170.00%In lineN/A50 up, 0 downMar 22, 2023N/A
    Sep 30, 2022-$0.33-$0.62-$0.73 - -$0.31+46.77%BeatN/A50 up, 0 downNov 10, 2022N/A
    Jun 30, 2022-$0.31-$0.67N/A+53.73%BeatN/AN/A0 up, 0 downAug 10, 2022N/A
    Mar 31, 2022-$0.29-$0.66-$1.00 - -$0.32+56.06%BeatN/A20 up, 0 downMay 11, 2022N/A
    Dec 31, 2021-$0.67-$1.28-$1.28 - -$0.22+47.66%BeatN/A40 up, 0 downMar 29, 2022N/A
    Sep 30, 2021-$0.13-$0.20-$0.22 - -$0.15+35.00%BeatN/A5N/ANov 15, 2021N/A
    Jun 30, 2021-$0.12-$0.18-$0.24 - -$0.13+33.33%BeatN/A50 up, 0 downAug 2, 2021$1.96M
    Mar 31, 2021-$0.12-$0.12N/A+4.17%BeatN/AN/AN/AJun 2, 2021$756000
    Dec 31, 2020-$0.12N/AN/AN/AN/AN/AN/AN/AMar 31, 2021$210000
    Dec 31, 2019-$0.11N/AN/AN/AN/AN/AN/AN/AMar 30, 2020N/A
    Last 25 quarters

    Annual EPS

    EPS for the fiscal year ended Dec 31, 2025 was -$0.59, after -$1.06 the year before. It was -$0.11 for the year ended Dec 31, 2019, the oldest of the 7 fiscal years shown.

    Fiscal year endedEPSChange
    Dec 31, 2025-$0.59N/A
    Dec 31, 2024-$1.06N/A
    Dec 31, 2023-$1.33N/A
    Dec 31, 2022-$1.28N/A
    Dec 31, 2021-$1.04N/A
    Dec 31, 2020-$0.12N/A
    Dec 31, 2019-$0.11N/A

    Frequently Asked Questions About RANI

    When is Rani Therapeutics Holdings's next earnings date?

    Rani Therapeutics Holdings's next earnings report is expected for Mar 25, 2027.

    Did RANI beat earnings estimates last quarter?

    Yes. Rani Therapeutics Holdings reported EPS of -$0.04 for the quarter ended Sep 30, 2026, above the -$0.05 estimate, a 20.00% surprise.

    What EPS do analysts expect from RANI next quarter?

    The consensus EPS estimate for Rani Therapeutics Holdings for the quarter ending Dec 31, 2026 is -$0.05 from 7 analysts, with estimates from -$0.06 to -$0.04.

    How often does RANI beat earnings estimates?

    Rani Therapeutics Holdings beat the EPS estimate in 4 of the last 8 quarters, with an average surprise of +0.30%.